Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment. It is important to target intensified therapy ...
Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...
CURE highlights prostate cancer advancements from Day One of the 2026 ASCO Genitourinary Cancers Symposium.
The combination antimicrobial TMP-SMZ should generally be avoided. Only the TMP penetrates the prostate, and its sulfa component may be nephrotoxic. Generally, if TMP is not available because of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results